http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20110120-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4a65a2b296613e73b5ea18acb9c4590 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4a69c7d77a9b4084b7fc05ba9616013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aceaaf78b4f37fbc1f412b95aff37240 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_145b7bd8354ea3c299628edb7368b9bc |
| publicationDate | 2011-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-20110120-A1 |
| titleOfInvention | SUCCINIC ACID SALT OF 1- [2- (2-CHLORO-4 - {[(R) -2-HYDROXY-2- (8-HYDROXY-2-OXO-1,2-DIHYDROQUINOLIN-5-IL) ETHYLAMINE] METHYL} -5-METOXYPHENYLCARBAMOYL) ETHYL] PIPERIDIN-4-IL ESTER OF BIPHENYL-2-ILCARBAMIC ACID |
| abstract | REFERS TO A SALT OF SUCCINIC ACID OF 1- [2- (2-CHLORO-4 - {[(R) -2-HYDROXY-2- (8-HYDROXY-2-OXO-1,2-DIHIDROQUINOLIN-5- IL) ETHYLAMINE] METHYL} -5-METOXYPHENYLCARBAMOYL) ETHYL] PIPERIDIN-4-IL ESTER OF BIPHENYL-2-ILCARBAMIC ACID CHARACTERIZED BY AN X-RAY DUST DIAPHRAGM (2TETA) OF 5.0, 5.7, 7.1, 10.0, 12.6, 13.8 , 14.4, 15.5, AMONG OTHERS; WITH A MELTING POINT OF 170 TO 180ºC. ALSO REFERRED TO A PREPARATION PROCESS AND TO A PHARMACEUTICAL COMPOSITION INCLUDING: A) SALT OF SUCCINIC ACID OF 1- [2- (2-CHLORO-4 - {[(R) -2-HYDROXY-2- (8-HYDROXY- 2-OXO-1,2-DIHYDROQUINOLIN-5-IL) ETHYLAMINE] METHYL} -5-METOXYPHENYLCARBAMOYL) ETHYL] PIPERIDIN-4-IL BIPHENYL-2-ILCARBAMIC ACID ESTER; B) A STEROID ANTI-INFLAMMATORY AGENT WHICH IS S-FLUOROMETHYL ESTER OF 6ALPHA ACID, 9ALPHA-DIFLUORO-17ALPHA - [(2-FURANYLCARBONYL) OXY] -11BETA-HYDROXY-16ALFA-METHYL-3-OXOANDROSETA-17 1,4-DIETHYL-17-1,4-DIETHYL-17 -CARBOTIOICON OR FLUTICASONE PROPIONATE; C) SELECTED VEHICLE OF KACTOSA, STARCH, MANNITOL, AMONG OTHERS. SUCH SALT IS SUITABLE FOR ADMINISTRATION BY INHALATION. SUCH FORMULATION PRESENTS AN ACCEPTABLE LEVEL OF HYGROSCOPICITY AND RELATIVELY HIGH FUSION POINT USEFUL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PULMO FIBROSIS, AMONG OTHERS |
| priorityDate | 2006-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.